Hologic (NASDAQ:HOLX) Releases FY 2024 Earnings Guidance : v

Hologic (NASDAQ:HOLX – Get Free Report) updated its FY 2024 earnings guidance on Friday. The company provided earnings per share (EPS) guidance of 4.020-4.120 for the period, compared to the consensus estimate of 4.030. The company issued revenue guidance of $4.0 billion-$4.1 billion, compared to the consensus revenue estimate of $4.0 billion. Hologic also updated […]

Related Keywords

Scottt Garrett , Charlesj Dockendorff , Raymond James , Citigroup , Hologic Inc , Securities Exchange Commission , Needham Company , Breast Health , Skeletal Health , Nasdaq , Hologic Company Profile , Get Free Report , Moderate Buy , Director Charles , Exchange Commission , Director Scott , Panther Fusion , Thinprep System , Rapid Fetal Fibronectin Test , Hologic Daily ,